Hypogonadism in Males With Genetic Neurodevelopmental Syndromes

J Clin Endocrinol Metab. 2022 Sep 28;107(10):e3974-e3989. doi: 10.1210/clinem/dgac421.

Abstract

Genetic syndromes that affect the nervous system may also disrupt testicular function, and the mechanisms for these effects may be interrelated. Most often neurological signs and symptoms predominate and hypogonadism remains undetected and untreated, while in other cases, a thorough evaluation of a hypogonadal male reveals previously unrecognized ataxia, movement disorder, muscle weakness, tremor, or seizures, leading to a syndromic diagnosis. Androgen deficiency in patients with neurological diseases may aggravate muscle weakness and fatigue and predispose patients to osteoporosis and obesity. The purpose of this mini review is to provide a current understanding of the clinical, biochemical, histologic, and genetic features of syndromes in which male hypogonadism and neurological dysfunction may coexist and may be encountered by the clinical endocrinologist.

Keywords: ataxia; hypogonadism; hypospermatogenesis; testosterone; weakness.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Androgens* / therapeutic use
  • Humans
  • Hypogonadism* / drug therapy
  • Male
  • Muscle Weakness / drug therapy
  • Syndrome
  • Testosterone / therapeutic use

Substances

  • Androgens
  • Testosterone